HK Stock Market Move | YOURAN DAIRY(09858) rises over 7% in the afternoon, full-year losses narrowing by nearly 40%, institutions are optimistic about the improvement of the core business profitability this year.
Yau Sum Livestock (09858) rose over 7% in the afternoon trading, as of the time of writing, up 7.37% to HK$4.08, with a trading volume of 1.14 billion Hong Kong dollars.
YOURAN DAIRY (09858) rose by more than 7% in the afternoon, with an increase of 7.37% by the time of publication, reaching HK$4.08 with a trading volume of HK$1.14 billion.
On the news front, YOURAN DAIRY announced its annual performance, achieving a total operating income of RMB 25.674 billion, a year-on-year growth of 4.51%. It reported a net loss of RMB 432 million, narrowing the loss by 37.42% year-on-year. Huatai stated that YOURAN DAIRY's performance was lower than expected mainly due to the disturbance of biological asset impairment, but the company has shown strong cost control ability and stable cash profits in the background of low raw milk prices and industry capacity digestion.
The bank believes that in the complex background of 25 years of low raw milk prices and continuous industry capacity digestion, the company has demonstrated strong cost control capabilities, with a 10.5% year-on-year decrease in kilogram feed costs, and a stable cash EBITDA, up by 4.9% year-on-year. Looking forward to 26, it is expected that milk prices will stabilize and rise, while beef cattle prices continue to rise, combined with the company's ongoing optimization of its cattle herd structure, the core business is expected to achieve profit improvement. The "buy" rating is maintained.
Related Articles

Zhejiang Hailide New Material (002206.SZ) plans to establish a wholly-owned subsidiary Zhejiang Hailide New Material Medical Technology Co., Ltd.

The Securities and Futures Commission of Hong Kong singled out IDT INT'L (00167) for its highly concentrated shareholding, with only 6.76% of the shares held by other shareholders.

Apeloa Pharmaceutical (000739.SZ) has obtained a drug registration certificate and a notice of approval for the listing application of chemical raw materials.
Zhejiang Hailide New Material (002206.SZ) plans to establish a wholly-owned subsidiary Zhejiang Hailide New Material Medical Technology Co., Ltd.

The Securities and Futures Commission of Hong Kong singled out IDT INT'L (00167) for its highly concentrated shareholding, with only 6.76% of the shares held by other shareholders.

Apeloa Pharmaceutical (000739.SZ) has obtained a drug registration certificate and a notice of approval for the listing application of chemical raw materials.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


